Free Newsletter
We're keeping up with you
Welcome to the first of FiercePharma Manufacturing's two issues this week! Your email in-box on Thursday will contain issue #2.

We're upping the frequency for two reasons. First is the need to keep pace with developments in pharmaceutical and bioprocessing operations. In spite of the poor economy, we've seen the industry gain momentum since we launched last summer. Business collaborations, facility openings, manufacturing practice updates, and supply chain advances are coming at us too quickly and at too great a volume to warrant just once-a-week coverage.
Second, our subscriber rolls have grown beyond our expectations. Although that's not by itself an indicator for a frequency increase, it's been accompanied by a swell of interest and participation from manufacturing service providers, product vendors, and industry groups--all of whom have something they want to say to you.
So enjoy this first of two issues this week. And know that you'll get another briefing as the week comes to a close.
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: